首页> 美国卫生研究院文献>other >Factors Determining Staphylococcus aureus Susceptibility to Photoantimicrobial Chemotherapy: RsbU Activity Staphyloxanthin Level and Membrane Fluidity
【2h】

Factors Determining Staphylococcus aureus Susceptibility to Photoantimicrobial Chemotherapy: RsbU Activity Staphyloxanthin Level and Membrane Fluidity

机译:确定金黄色葡萄球菌对光抗菌化学药物敏感性的因素:RsbU活性金黄色葡萄黄素水平和膜流动性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Photoantimicrobial chemotherapy (PACT) constitutes a particular type of stress condition, in which bacterial cells induce a pleiotropic and as yet unexplored effect. In light of this, the key master regulators are of putative significance to the overall phototoxic outcome. In Staphylococcus aureus, the alternative sigma factor σB controls the expression of genes involved in the response to environmental stress. We show that aberration of any sigB operon genes in S. aureus USA300 isogenic mutants causes a pronounced sensitization (>5 log10 reduction in CFU drop) to PACT with selected photosensitizers, namely protoporphyrin diarginate, zinc phthalocyanine and rose bengal. This effect is partly due to aberration-coupled staphyloxanthin synthesis inhibition. We identified frequent mutations in RsbU, a σB activator, in PACT-vulnerable clinical isolates of S. aureus, resulting in σB activity impairment. Locations of significant changes in protein structure (IS256 insertion, early STOP codon occurrence, substitutions A230T and A276D) were shown in a theoretical model of S. aureus RsbU. As a phenotypic hallmark of PACT-vulnerable S. aureus strains, we observed an increased fluidity of bacterial cell membrane, which is a result of staphyloxanthin content and other yet unidentified factors. Our research indicates σB as a promising target of adjunctive antimicrobial therapy and suggests that enhanced cell membrane fluidity may be an adjuvant strategy in PACT.
机译:光抗菌化学疗法(PACT)构成了一种特殊的应激状态,其中细菌细胞诱导多效且尚未探索的作用。有鉴于此,关键的主调节剂对总体光毒性结果具有假定的重要性。在金黄色葡萄球菌中,替代的sigma因子σ B 控制与环境胁迫有关的基因的表达。我们显示,在金黄色葡萄球菌USA300同基因突变体中,任何sigB操纵子基因的畸变都会对PACT产生明显的敏化作用(CFU下降降低> 5 log10),这与原光敏化剂精氨酸,精氨酸锌,酞菁锌和玫瑰红有关。该作用部分归因于像差耦合的葡萄黄素合成抑制。我们在易受PACT感染的金黄色葡萄球菌临床分离株中发现了σ B 激活剂RsbU的频繁突变,从而导致σ B 活性受损。在金黄色葡萄球菌RsbU的理论模型中显示了蛋白质结构显着变化的位置(IS256插入,早期STOP密码子出现,替代A230T和A276D)。作为易受PACT感染的金黄色葡萄球菌菌株的表型特征,我们观察到细菌细胞膜的流动性增加,这是葡萄黄素含量和其他未知因素的结果。我们的研究表明σ B 是辅助抗菌治疗的有希望的靶标,并表明增强细胞膜流动性可能是PACT的辅助策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号